Logo image of TRZ.CA

TRANSAT A.T. INC (TRZ.CA) Stock Fundamental Analysis

TSX:TRZ - Toronto Stock Exchange - CA89351T4019 - Common Stock - Currency: CAD

2.61  -0.04 (-1.51%)

Fundamental Rating

2

TRZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 9 industry peers in the Passenger Airlines industry. TRZ has a bad profitability rating. Also its financial health evaluation is rather negative. TRZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year TRZ has reported negative net income.
In the past year TRZ had a positive cash flow from operations.
TRZ had negative earnings in each of the past 5 years.
In multiple years TRZ reported negative operating cash flow during the last 5 years.
TRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFTRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -5.09%, TRZ perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
TRZ's Return On Invested Capital of 2.72% is on the low side compared to the rest of the industry. TRZ is outperformed by 77.78% of its industry peers.
Industry RankSector Rank
ROA -5.09%
ROE N/A
ROIC 2.72%
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRZ.CA Yearly ROA, ROE, ROICTRZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

With a Operating Margin value of 1.34%, TRZ is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
TRZ's Gross Margin of 49.13% is in line compared to the rest of the industry. TRZ outperforms 55.56% of its industry peers.
TRZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.34%
PM (TTM) N/A
GM 49.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
TRZ.CA Yearly Profit, Operating, Gross MarginsTRZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TRZ is destroying value.
TRZ has more shares outstanding than it did 1 year ago.
TRZ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for TRZ is higher compared to a year ago.
TRZ.CA Yearly Shares OutstandingTRZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
TRZ.CA Yearly Total Debt VS Total AssetsTRZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.48, we must say that TRZ is in the distress zone and has some risk of bankruptcy.
TRZ's Altman-Z score of 0.48 is on the low side compared to the rest of the industry. TRZ is outperformed by 88.89% of its industry peers.
TRZ has a debt to FCF ratio of 26.00. This is a negative value and a sign of low solvency as TRZ would need 26.00 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 26.00, TRZ is in line with its industry, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 26
Altman-Z 0.48
ROIC/WACC0.71
WACC3.86%
TRZ.CA Yearly LT Debt VS Equity VS FCFTRZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

TRZ has a Current Ratio of 0.76. This is a bad value and indicates that TRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
TRZ has a Current ratio of 0.76. This is in the lower half of the industry: TRZ underperforms 66.67% of its industry peers.
TRZ has a Quick Ratio of 0.76. This is a bad value and indicates that TRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of TRZ (0.74) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.74
TRZ.CA Yearly Current Assets VS Current LiabilitesTRZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

TRZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.42%.
The Revenue has been growing slightly by 3.55% in the past year.
The Revenue has been growing slightly by 2.26% on average over the past years.
EPS 1Y (TTM)-36.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.76%
Revenue 1Y (TTM)3.55%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%5.95%

3.2 Future

The Earnings Per Share is expected to grow by 24.21% on average over the next years. This is a very strong growth
TRZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.74% yearly.
EPS Next Y10.7%
EPS Next 2Y20.73%
EPS Next 3Y24.21%
EPS Next 5YN/A
Revenue Next Year5.3%
Revenue Next 2Y4.71%
Revenue Next 3Y4.74%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TRZ.CA Yearly Revenue VS EstimatesTRZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TRZ.CA Yearly EPS VS EstimatesTRZ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

3

4. Valuation

4.1 Price/Earnings Ratio

TRZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TRZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRZ.CA Price Earnings VS Forward Price EarningsTRZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TRZ is valued a bit cheaper than 77.78% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, TRZ is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.31
EV/EBITDA 5.72
TRZ.CA Per share dataTRZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as TRZ's earnings are expected to grow with 24.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.73%
EPS Next 3Y24.21%

0

5. Dividend

5.1 Amount

No dividends for TRZ!.
Industry RankSector Rank
Dividend Yield N/A

TRANSAT A.T. INC

TSX:TRZ (7/25/2025, 7:00:00 PM)

2.61

-0.04 (-1.51%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)06-10 2025-06-10/amc
Earnings (Next)09-10 2025-09-10/amc
Inst Owners26.26%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap104.74M
Analysts47.27
Price Target3.11 (19.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.22%
Min EPS beat(2)9.56%
Max EPS beat(2)112.88%
EPS beat(4)3
Avg EPS beat(4)79.93%
Min EPS beat(4)-93.62%
Max EPS beat(4)290.9%
EPS beat(8)5
Avg EPS beat(8)226.17%
EPS beat(12)8
Avg EPS beat(12)159.39%
EPS beat(16)8
Avg EPS beat(16)115.22%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-0.38%
Max Revenue beat(2)1.08%
Revenue beat(4)2
Avg Revenue beat(4)0.21%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)3.03%
Revenue beat(8)5
Avg Revenue beat(8)0.33%
Revenue beat(12)6
Avg Revenue beat(12)-0.66%
Revenue beat(16)7
Avg Revenue beat(16)-1.81%
PT rev (1m)0%
PT rev (3m)98.05%
EPS NQ rev (1m)56.08%
EPS NQ rev (3m)56.08%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.25%
Revenue NQ rev (3m)-1.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF 1.31
P/OCF 0.59
P/B N/A
P/tB N/A
EV/EBITDA 5.72
EPS(TTM)-2.21
EYN/A
EPS(NY)-1.93
Fwd EYN/A
FCF(TTM)1.99
FCFY76.2%
OCF(TTM)4.42
OCFY169.16%
SpS84.37
BVpS-25.76
TBVpS-26.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.09%
ROE N/A
ROCE 3.78%
ROIC 2.72%
ROICexc 4.89%
ROICexgc 4.99%
OM 1.34%
PM (TTM) N/A
GM 49.13%
FCFM 2.36%
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
F-Score2
Asset Turnover1.2
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 26
Debt/EBITDA 6.66
Cap/Depr 40.14%
Cap/Sales 2.88%
Interest Coverage 0.41
Cash Conversion 61.51%
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.74
Altman-Z 0.48
F-Score2
WACC3.86%
ROIC/WACC0.71
Cap/Depr(3y)38.18%
Cap/Depr(5y)29.63%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.76%
EPS Next Y10.7%
EPS Next 2Y20.73%
EPS Next 3Y24.21%
EPS Next 5YN/A
Revenue 1Y (TTM)3.55%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%5.95%
Revenue Next Year5.3%
Revenue Next 2Y4.71%
Revenue Next 3Y4.74%
Revenue Next 5YN/A
EBIT growth 1Y15.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year503.88%
EBIT Next 3Y102.67%
EBIT Next 5YN/A
FCF growth 1Y-64.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.6%
OCF growth 3YN/A
OCF growth 5Y-15.21%